Will I need to urinate more often
00:02:16 Vickie Danaher For instance, oral liquid dosage forms provide more options for patients with dysphagia or difficulty swallowing pills, especially in our older patients or pediatric patient populations
Tirzepatide, a dual GIP and GLP-1 receptor agonist, has been shown to reduce hepatic steatosis in MASLD (Targher et al., 2023[76], 2025[77])
The harder population to reach is the one without a diabetes diagnosis, members who are overweight or have obesity and carry cardiovascular risk, perhaps taking a statin or a blood pressure medication, but whose A1C hasn't yet crossed the threshold for a diabetes diagnosis
This involves addressing emotional eating, developing healthier coping mechanisms, and cultivating positive habits that support a healthier lifestyle
What qualifications should the prescribing physician have for GLP-1 therapy? The prescriber should be a licensed physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) with prescribing authority in Texas and demonstrated experience managing GLP-1 dose titration, side effect protocols, and metabolic adaptation during weight loss